Earnest Partners LLC Trims Stock Holdings in Humana Inc. (NYSE:HUM)

Earnest Partners LLC trimmed its holdings in Humana Inc. (NYSE:HUM - Free Report) by 33.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,502 shares of the insurance provider's stock after selling 16,646 shares during the period. Earnest Partners LLC's holdings in Humana were worth $8,500,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of HUM. VeriStar Capital Management LP boosted its holdings in Humana by 16.3% in the 4th quarter. VeriStar Capital Management LP now owns 25,239 shares of the insurance provider's stock valued at $6,403,000 after purchasing an additional 3,539 shares during the period. Boothbay Fund Management LLC boosted its holdings in Humana by 196.2% in the 4th quarter. Boothbay Fund Management LLC now owns 13,254 shares of the insurance provider's stock valued at $3,363,000 after purchasing an additional 8,779 shares during the period. Kovitz Investment Group Partners LLC boosted its holdings in Humana by 87.7% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 7,845 shares of the insurance provider's stock valued at $1,990,000 after purchasing an additional 3,666 shares during the period. Symmetry Investments LP bought a new position in Humana in the 4th quarter valued at $551,000. Finally, T. Rowe Price Investment Management Inc. boosted its holdings in Humana by 11.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,605,771 shares of the insurance provider's stock valued at $407,401,000 after purchasing an additional 160,952 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on HUM. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Mizuho raised their price target on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. JPMorgan Chase & Co. cut their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Barclays lifted their price objective on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a report on Friday, April 11th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $284.90.

Humana Price Performance

Shares of HUM stock opened at $263.92 on Monday. The firm has a market cap of $31.85 billion, a P/E ratio of 26.52, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The business's 50 day moving average price is $266.35 and its 200-day moving average price is $270.81. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Friday, June 27th. Humana's payout ratio is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.